The global cellular health screening market size was valued at USD 2.78 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 9.2% from 2023 to 2030.
Over the projected period, the importance of precision medicine is expected to increase along with the requirement to analyze biomarkers for aging and cellular health in general....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian